News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

LDR Files for IPO, Aims to Raise $69 Million



8/27/2013 7:09:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LDR Files Registration Statement for Proposed Initial Public Offering

AUSTIN, Texas--(BUSINESS WIRE)--LDR Holding Corporation announced today that it has filed a registration on Form S-1 with the Securities and Exchange Commission (“SEC”) for a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have yet to be determined. LDR plans to list its common stock on the NASDAQ Global Select Market under the ticker symbol “LDRH.”

Piper Jaffray & Co., William Blair & Company, L.L.C. and Bryan, Garnier & Co. will act as joint book-running managers for the proposed offering and Cowen and Company, LLC, JMP Securities LLC and Stephens Inc. will act as co-managers.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus related to the offering may be obtained from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at (800) 747-3924, or email at prospectus@pjc.com; William Blair & Company L.L.C., Attention: Prospectus Department, 222 West Adams Street, Chicago, IL 60606, telephone: (800) 621-0687, or email: prospectus@williamblair.com; or from Bryan, Garnier & Co., Attention: Prospectus Department 26, avenue des Champs-Élysées, 75008 Paris France or email: prospectus@bryangarnier.com.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About LDR

LDR, founded in Troyes, France, and headquartered in Austin, Texas, is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. Exclusive LDR technologies are based on the Mobi non-fusion and VerteBRIDGE® fusion platforms which have applications in cervical and lumbar spine. In addition to Austin and Troyes, LDR has regional offices in Germany, Spain, China, South Korea and Brazil. More information regarding LDR can be found at www.ldr.com.

Contacts

Media:

For LDR Holding Corporation

Gabrielle Zucker, (646) 747-7143

Gzucker@kwitco.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
LDR
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES